Annabel E Smith

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Cerebrospinal Fluid

Mesenchymal Stem Cells

Top Venues

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan Benn, Shi Cheng, Sophie Keeling, Annabel E Smith, Marina J Vaysburd, Dorothea Böken, Lauren V C Miller, Taxiarchis Katsinelos, Catarina Franco, Elian Dupré, Clément Danis, Isabelle Landrieu, Luc Buee, David Klenerman, Leo C James, William A McEwan
Aggregate-selective removal of pathological tau by clustering-activated degraders. Science (New York, N.Y.) 385 (6712) (2024)
Aamir S Mukadam, Lauren V C Miller, Annabel E Smith, Marina Vaysburd, Siri Aastedatter Sakya, Sophie A I Sanford, Sophie Keeling, Benjamin J Tuck, Taxiarchis Katsinelos, Christopher Green, Lise R Skov, Sanne Simone Kaalund, Stian Foss, Keith Mayes, Kevin O'Connell, Mark Wing, Claire Knox, Jessica Banbury, Edward Avezov, James Benedict Rowe, Michel Goedert, Jan Terje Andersen, Leo C James, William A McEwan
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models. Science (New York, N.Y.) 379 (6639) (2023)
Aamir S Mukadam, Lauren V C Miller, Annabel E Smith, Marina Vaysburd, Siri Aastedatter Sakya, Sophie A I Sanford, Sophie Keeling, Benjamin J Tuck, Taxiarchis Katsinelos, Christopher Green, Lise R Skov, Sanne Simone Kaalund, Stian Foss, Keith Mayes, Kevin O'Connell, Mark Wing, Claire Knox, Jessica Banbury, Edward Avezov, James Benedict Rowe, Michel Goedert, Jan Terje Andersen, Leo C James, William A McEwan
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models. Science (New York, N.Y.) 379 (6639) (2023)